Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 059911/0731 | |
| Pages: | 42 |
| | Recorded: | 05/09/2022 | | |
| Attorney Dkt #: | PAT058541-US-PCT STEP I |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17633495
|
Filing Dt:
|
02/07/2022
|
|
Publication #:
|
|
Pub Dt:
|
09/15/2022
| | | | |
|
Title:
|
HETEROCYCLIC WDR5 INHIBITORS AS ANTI-CANCER COMPOUNDS
|
|
|
Assignee
|
|
|
|
|
| 4218 JINKE ROAD, ZHANGJIANG HI-TECH PARK |
| PUDONG NEW AREA |
| SHANGHAI, CHINA 201203 |
|
|
Correspondence name and address
|
| |
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC.
|
| |
5959 HORTON STREET, 9TH FLOOR
|
| |
EMERYVILLE, CA 94608
|
Search Results as of:
05/01/2024 09:08 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
